Global Gene Expression Analysis Market Size, Share, and COVID-19 Impact Analysis, By Product (Reagents, Enzymes, Kits, DNA Chips, PCR, NGS, and DNA Microarray), By Service (RNA Sequencing and Bioinformatics), By Application (Drug discovery & Development and Clinical Diagnostics), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global Gene Expression Analysis Market Insights Forecasts to 2035

• The Global Gene Expression Analysis Market Size Was Estimated at USD 4.22 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 8.17% from 2025 to 2035
• The Worldwide Gene Expression Analysis Market Size is Expected to Reach USD 10.01 Billion by 2035
• Asia Pacific is expected to grow the fastest during the forecast period.

According to a research report published by Spherical Insights and Consulting, The Global Gene Expression Analysis Market Size was worth around USD 4.22 Billion in 2024 and is predicted to grow to around USD 10.01 Billion by 2035 with a compound annual growth rate (CAGR) of 8.17 % from 2025 to 2035. The gene expression analysis market offers future opportunities through expanding precision medicine, rising genomic research funding, advancements in RNA sequencing, and integration of AI-driven bioinformatics tools to accelerate diagnostics, drug discovery, and personalized therapeutic development.

Global Gene Expression Analysis Market Forecast and Revenue Outlook

• 2024 Market Size: USD 4.22 Billion
• 2035 Projected Market Size: USD 10.01 Billion
• CAGR (2025-2035): 8.17%
• North America: Largest market in 2024
• Asia Pacific: Fastest growing market

Market Overview

The gene expression analysis market is experiencing robust growth, driven by advancements in genomics, transcriptomics, and next-generation sequencing technologies. It involves studying RNA transcripts to understand gene activity, disease mechanisms, and therapeutic targets. Increasing demand for precision medicine, biomarker discovery, and cancer diagnostics is accelerating adoption. Government funding and large-scale initiatives, such as the Human Cell Atlas and cancer genome projects, further support market expansion. However, high costs of sequencing platforms and data analysis tools remain a challenge. With growing integration of AI-based bioinformatics and cloud solutions, the market is expected to witness sustained innovation and strong global demand.

Key Market Insights

• North America is expected to account for the largest share in the gene expression analysis market during the forecast period.
• In terms of product, the Kits segment is projected to lead the gene expression analysis market throughout the forecast period
• In terms of service, the RNA sequencing segment captured the largest portion of the market
• In terms of application, the drug discovery & development segment is projected to lead the gene expression analysis market throughout the forecast period

Gene Expression Analysis Market Trends

• Rising Adoption in Personalized Medicine: Increased use of gene expression profiling for tailored treatment plans in oncology and chronic diseases.
• Growth in NGS and PCR Technologies: Next-generation sequencing (NGS) and PCR-based platforms are driving high-throughput and accurate gene expression analysis.
• Expansion of Clinical Diagnostics: Growing use of gene expression in early disease detection, prognosis, and rare disease diagnostics.
• Integration of Bioinformatics: Advanced software tools are enabling large-scale data analysis and interpretation of gene expression results.
• Increasing R&D Investments: Pharmaceutical and biotech companies investing in drug discovery and target validation using gene expression studies.

Report Coverage

This research report categorizes the gene expression analysis market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyzes the key growth drivers, opportunities, and challenges influencing the gene expression analysis market. Recent market developments and competitive strategies, such as expansion, type launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyzes their core competencies in each sub-segment of the gene expression analysis market.

Driving factors

Key driving factors for the gene expression analysis market include the rising demand for precision medicine and personalized therapies, which rely heavily on transcriptomic insights for targeted treatment development. Growing prevalence of chronic diseases, especially cancer and neurological disorders, is fueling the adoption of advanced gene expression profiling technologies. Additionally, advancements in next-generation sequencing (NGS), microarrays, and PCR platforms have significantly improved accuracy, speed, and affordability of analysis. Expanding government initiatives, research funding, and large-scale genomics projects are also accelerating market growth. Furthermore, increasing collaborations between biotech firms, pharma companies, and academic institutions are fostering innovation and commercialization opportunities.

Restraining Factor

The gene expression analysis market faces restraints due to high costs of advanced technologies, complex data interpretation, and limited skilled professionals. Additionally, strict regulatory requirements and ethical concerns over genetic data handling hinder widespread adoption and slow commercialization.

Market Segmentation 

The global gene expression analysis market is divided into product, service, and application.

Global Gene Expression Analysis Market, By Product:

• The kits segment dominated the market in 2024 and is projected to grow at approximately 10.5% CAGR during the forecast period.   

Based on product, the global gene expression analysis market is segmented into, reagents, enzymes, kits, DNA chips, PCR, NGS, and DNA microarray. Among these, the kits segment dominated the market in 2024 and is projected to grow at approximately 10.5% CAGR during the forecast period. Driven by rising demand for standardized workflows, expansion of precision medicine, and increasing usage in oncology and infectious disease research. Kits also reduce turnaround time and enhance reproducibility, making them the preferred choice for both academic and clinical applications, thereby securing their strong market position.

The NGS (next-generation sequencing) segment is expected to be the fastest-growing in the gene expression analysis market during the forecast period. Growth is fueled by increasing adoption of NGS-based transcriptomics for large-scale, high-throughput analysis, declining sequencing costs, and its ability to provide deeper insights into complex diseases like cancer, neurological disorders, and rare genetic conditions. 

Global Gene Expression Analysis Market, By Service:

• The RNA Sequencing segment accounted for the largest share in 2024 and is anticipated to grow at a 10.1% CAGR during the forecast period.

Based on service, the global gene expression analysis market is segmented into RNA sequencing and bioinformatics. Among these, the RNA sequencing segment accounted for the largest share in 2024 and is anticipated to grow at a 10.1% CAGR during the forecast period. Growth is supported by increasing applications in disease research, drug discovery, and personalized medicine, along with declining sequencing costs and expanding adoption in both academic and clinical research. Meanwhile, the bioinformatics segment, although smaller, is rapidly expanding due to rising demand for advanced data analysis and interpretation tools.

The bioinformatics segment in the gene expression analysis market is expected to grow at the fastest CAGR over the forecast period. This rapid growth is driven by the increasing complexity of large-scale genomic datasets, the need for advanced computational tools for analysis and interpretation, and rising adoption of AI- and cloud-based platforms.

Global Gene Expression Analysis Market, By Application:

• The Drug discovery & Development segment accounted for the largest share in 2024 and is anticipated to grow at a 9.5% CAGR during the forecast period.

Based on application, the global gene expression analysis market is segmented into drug discovery & development and clinical diagnostics. Among these, the drug discovery & development segment accounted for the largest share in 2024 and is anticipated to grow at a 9.5% CAGR during the forecast period. This is attributed by rising pharmaceutical R&D investments, growing demand for precision medicine, and the integration of high-throughput sequencing with gene expression profiling to accelerate drug pipelines. Increasing collaboration between biotech firms and pharmaceutical companies further strengthens this segment’s dominance in the global market.

The clinical diagnostics segment in the gene expression analysis market is expected to grow at the fastest CAGR over the forecast period. This growth is fueled by rising demand for personalized medicine, early disease detection, and the increasing use of gene expression profiling in oncology, infectious diseases, and rare genetic disorder diagnostics.

Regional Segment Analysis of the Global Gene Expression Analysis Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America Gene Expression Analysis Market Trends

North America is expected to hold the largest share of the global gene expression analysis market over the forecast period.

North America is expected to hold the largest share of the global gene expression analysis market over the forecast period. In 2024, North America accounted for over 47% of the global market revenue. North America boasts a robust healthcare system with significant investments in research and development, facilitating the adoption of cutting-edge technologies in gene expression analysis.

U.S. Gene Expression Analysis Market Trends

The U.S. market leads globally, driven by advanced healthcare infrastructure, high R&D investment, and strong biotech and pharmaceutical sectors. Growth is fueled by personalized medicine adoption, government genomics initiatives, and increasing use of high-throughput gene expression technologies.

Canada Gene Expression Analysis Market Trends

Canada’s gene expression market is expanding steadily due to supportive government funding, rising genomics research, and growing demand for precision medicine. Increasing collaborations between academic institutions and biotech firms, along with technological advancements, are driving adoption across healthcare and research sectors.

Asia Pacific is expected to grow at the fastest CAGR in the gene expression analysis market during the forecast period.

Asia Pacific is expected to grow at the fastest CAGR in the gene expression analysis market during the forecast period. This growth is driven by several key factors such as countries in the APAC region are increasing their investments in genomics research and precision medicine, fostering an environment conducive to market expansion. There is a rise in partnerships between academic institutions and industry players, enhancing research capabilities and technological advancements.

India Gene Expression Analysis Market Trends

India’s market is rapidly growing due to advancements in omics technologies, precision medicine, cancer research, and pharmaceutical R&D. Government support, adoption of innovative sequencing tools, and applications in agriculture and personalized therapies are driving strong market expansion.

China Gene Expression Analysis Market Trends

China’s market is expanding swiftly, fueled by government funding, biotech initiatives, academic-industry collaborations, and advanced healthcare infrastructure. Technological innovations in gene expression analysis and strategic focus on genomics and precision medicine are accelerating adoption and market growth across research and diagnostics.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global gene expression analysis market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

Worldwide Top Key Players in The Gene Expression Analysis Market Include

• QIAGEN
• Quest Diagnostics Incorporated
• F. Hoffmann-La Roche Ltd
• Illumina, Inc.
• Novogene Co., Ltd.
• PerkinElmer
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific Inc.
• Agilent Technologies, Inc.
• General Electric Company
• Promega Corporation
• DiaSorin S.p.A.
• Takara Bio Inc.
• Merck & Co., Inc.
• Genotypic Technology Pvt Ltd

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent development

• In May 2025, A recent review in Clinical Epigenetics highlights the growing role of DNA methylation in cancer diagnosis, prognosis, and treatment. It discusses current profiling technologies, identifies key methylation hotspots, and evaluates the clinical impact of epigenetic therapies, or "epidrugs," in advancing personalized medicine.

• In March 2025, A recent study published in Scientific Reports introduces a computational framework to analyze inter-tissue gene expression coordination changes with aging. By applying this model to adipose, muscle, and brain tissues, researchers identified key genes and pathways, such as lipid metabolism and immune system processes, that play crucial roles in aging across multiple tissues. The Random Forest model achieved an accuracy of over 88% in predicting age groups, highlighting the potential of this approach in understanding aging mechanisms and developing therapeutic strategies for healthy aging.

Market Segment

This study forecasts revenue at the global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the gene expression analysis market based on the following segments:

Global Gene Expression Analysis Market, By Product

• Reagents
• Enzymes
• Kits
• DNA Chips
• PCR
• NGS
• DNA Microarray

Global Gene Expression Analysis Market, By Service

• RNA Sequencing
• Bioinformatics

Global Gene Expression Analysis Market, By Application

• Drug discovery & Development
• Clinical Diagnostics

Global Gene Expression Analysis Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa